|
2009 World Molecular Imaging Congress
|
1R13CA142041-01
|
$5,000
|
ACKERMAN, JOSEPH
|
SOCIETY FOR MOLECULAR IMAGING
|
|
A Phase I Trial of CC-5013 (lenalidomide) in Pediatric Patients with Recurrent or
|
ZIA BC 010585
|
$24,404
|
Warren, Katherine
|
CCR (NCI)
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S1
|
$114,606
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
3P30CA016520-34S3
|
$100,000
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center of the U of P Core Support Grant
|
5P30CA016520-34
|
$7,326,647
|
Thompson, Craig
|
UNIVERSITY OF PENNSYLVANIA
|
|
An Exploratory Study of Biologic and Pathophysiologic Efects of Radiation Therap
|
ZIA BC 010709
|
$97,616
|
Warren, Katherine
|
CCR (NCI)
|
|
Anatomic Pathology Residency Program
|
ZIE BC 010684
|
$1,339,887
|
Jaffe, Elaine
|
CCR (NCI)
|
|
Anticancer Drug Development for Childhood Cancers
|
ZIA SC 006880
|
$831,277
|
Balis, Frank
|
CCR (NCI)
|
|
Bcl-2 family proteins in the ER-mediated apoptosis
|
5K01CA098092-06
|
$124,308
|
ZONG, WEI-XING
|
STATE UNIVERSITY NEW YORK STONY BROOK
|
|
Biochemical Analysis of Multidrug Resistance-linked Transport Proteins
|
ZIA BC 010030
|
$728,095
|
Ambudkar, Suresh
|
CCR (NCI)
|
|
BIOINFORMATICS: SYSTEMS BIOLOGY OF NEUROBLASTOMA
|
ZIA BC 011002
|
$172,158
|
Khan, Javed
|
CCR (NCI)
|
|
Brain Tumor Animal Therapeutics Core
|
ZIC BC 011086
|
$607,472
|
Fine, Howard
|
CCR (NCI)
|
|
Brain Tumor Clinical and Clinical Research Program
|
ZID BC 011098
|
$2,159,900
|
Fine, Howard
|
CCR (NCI)
|
|
Building on the success of the adoptive immunotherapy of cancer
|
ZIA BC 010763
|
$1,313,626
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Cancer Center Clinical Trials Reporting Program (CTRP) Early Adopters
|
3P30CA013696-36S1
|
$99,928
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
Cancer Center Support (Core) Grant
|
5P30CA014051-38
|
$2,844,058
|
JACKS, TYLER
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-34S1
|
$113,210
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-34S2
|
$124,410
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support (Core) Grant
|
3P30CA016672-34S3
|
$99,940
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support (Core) Grant
|
5P30CA016672-34
|
$10,451,830
|
MENDELSOHN, JOHN
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Cancer Center Support Grant
|
5P30CA013696-36
|
$3,999,822
|
DALLA-FAVERA, RICCARDO
|
COLUMBIA UNIVERSITY HEALTH SCIENCES
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S1
|
$124,531
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S2
|
$100,000
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
3P30CA006516-45S5
|
$143,383
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
CANCER CENTER SUPPORT GRANT
|
5P30CA006516-45
|
$11,688,901
|
BENZ, EDWARD
|
DANA-FARBER CANCER INSTITUTE
|
|
Cancer Genomics Technology Development
|
ZIA BC 011091
|
$1,069,901
|
Meltzer, Paul
|
CCR (NCI)
|
|
Canine Glioma and Embryonic Neural Stem Cell Project
|
ZIA BC 011099
|
$472,478
|
Fine, Howard
|
CCR (NCI)
|
|
Center for Applied Preclinical Research (CAPR)
|
ZIC BC 011137
|
$1,339,520
|
Van Dyke, Terry
|
CCR (NCI)
|
|
Clinical Development of Novel Drugs for Children with Refractory Cancers
|
ZIA SC 010354
|
$179,821
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Clinical Nursing and Data Management Core
|
ZID BC 011089
|
$1,027,647
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical Pharmacogenetics
|
ZIA BC 010627
|
$438,328
|
Figg, William
|
CCR (NCI)
|
|
Clinical Pharmacology of Anticancer Drugs
|
ZIA BC 011080
|
$923,641
|
Balis, Frank
|
CCR (NCI)
|
|
Clinical Studies of the Molecular Genetic Basis of Kidney Cancer
|
ZIA BC 011028
|
$513,824
|
Linehan, W. Marston
|
CCR (NCI)
|
|
Clinical trials of patients with AIDS-related malignancies
|
ZIA BC 010888
|
$760,989
|
Yarchoan, Robert
|
CCR (NCI)
|
|
Clinical Trials with Immunotoxins
|
ZIA BC 010020
|
$633,926
|
Pastan, Ira
|
CCR (NCI)
|
|
CNS sirtuins in radiation-induced vascular permeability and neurodegeneration
|
ZIA BC 011222
|
$106,223
|
Smart, DeeDee
|
CCR (NCI)
|
|
Comparative Genomic Hybridization of Neuroblastoma
|
ZIA BC 010592
|
$57,386
|
Khan, Javed
|
CCR (NCI)
|
|
Complex Human Diseases - From Gene to Function to Therapy
|
ZIA BC 005725
|
$517,266
|
Dean, Michael
|
CCR (NCI)
|
|
Connecting PTEN and NF2 cancer predisposition syndromes
|
5R01CA107201-05
|
$254,494
|
GEORGESCU, MARIA-MAGDALENA
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Consequences of receptor cross talk on inflammation and algesia
|
ZIA BC 010708
|
$60,820
|
Oppenheim, Joost
|
CCR (NCI)
|
|
Convection enhanced delivery of agents into the brainstem of patients with diff
|
ZIA BC 010800
|
$48,808
|
Warren, Katherine
|
CCR (NCI)
|
|
Cutaneous Lesions in Neurofibromatosis Type I and Other Pre-cancerous Syndromes
|
ZIA BC 010734
|
$43,418
|
Hornyak, Thomas
|
CCR (NCI)
|
|
Cytokine Regulation of Normal and Neoplastic Hematopoietic Cell Growth
|
ZIA BC 009264
|
$576,162
|
Ruscetti, Francis
|
CCR (NCI)
|
|
Determining the Fate of Transmembrane Proteins
|
ZIA BC 009392
|
$762,837
|
Weissman, Allan
|
CCR (NCI)
|
|
Developing Improved Methods for Modeling and Simulating Protein Structures
|
ZIA BC 011060
|
$128,574
|
Guy, H. Robert
|
CCR (NCI)
|
|
Developing new immunotherapies based of CD4+ T cells
|
ZIA BC 011037
|
$647,010
|
Restifo, Nicholas
|
CCR (NCI)
|
|
Development of Mouse Astrocytoma Model for Preclinical Testing
|
ZIA BC 010541
|
$98,553
|
Reilly, Karlyne
|
CCR (NCI)
|
|
Development of Therapies for Neurofibromatosis Type 1 Related Tumors and other Ge
|
ZIA BC 010801
|
$419,583
|
Widemann, Brigitte
|
CCR (NCI)
|
|
Differential Gene Expression and Targeting of Gliomas Using Radiation
|
ZIA BC 011018
|
$48,808
|
Warren, Katherine
|
CCR (NCI)
|
|
Differentiation of tissue- and devlopment of tumor stem cells
|
ZIA BC 010796
|
$252,575
|
Niederhuber, John
|
CCR (NCI)
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|